Howorth Air Tech

Howorth Air Tech

Rugby League Cares works alongside Howorth Air Tech to deliver an inspirational and worthwhile employee wellbeing and leadership programme..

Howorth Air Tech is a Bolton-based air engineering company which delivers controlled clean environments for the healthcare and pharmaceutical industries.

The company’s passion for air quality began in 1858 in the poorly ventilated cotton mills of Lancashire. With a vision to protect workers, founder James Howorth began manufacturing apparatus that would provide ventilation and drastically improve air quality. It would transform the lives and working conditions in the textile industry.

In the early 1960s, Howorth’s experience and skills were applied in response to the needs of the medical profession. Working in close collaboration with renowned orthopaedic surgeon, Sir John Charnley, Howorth designed and developed the world’s first Ultra Clean Ventilation (UCV) system for operating theatres.

From this pioneering first step, the company went on to create the Howorth Exflow™ UCV which, in its current derivation, remains a global leader in the field of ultra clean ventilation. In addition to the Exflow, Howorth also provides a broad range of additional products and services for the medical market, ranging from operating theatre lighting and ceiling service units to complete turnkey healthcare facilities.

The Howorth Exflow™ UCV, as it is now known, remains a global leader in the field of ultra clean ventilation. As a supplier and partner to global biopharma companies for many years, Howorth understand the increasingly onerous international health and safety standards that its clients are expected to meet. Howorth provides a full range of aseptic and containment barrier solutions developed specifically for the biopharmaceutical and pharmaceutical industry.

Today, this expertise in engineering clean air is fundamental to Howorth’s success in providing world-class containment and infection control solutions, serving the global pharmaceutical and wider industrial markets; process, production, pharma, bio-technology, contract facilities. Recently there have been advancements made within the rapidly growing biotechnology industry which has resulted in an increased demand for new facilities that address their particular drivers and requirements.